Icosapent Ethyl May Have Anti-inflammatory Effect In Patients With Symptomatic COVID-19, Study Suggests

Healio (12/16, Swain) reports on research finding that “icosapent ethyl reduced levels of inflammatory biomarkers and improved symptoms in patients with COVID-19.” Deepak L. Bhatt, MD, MPH, of Brigham and Women’s Hospital and Harvard Medical School, said,...